Análisis in silico de algunas mutaciones presentes en el gen pncA de Mycobacterium tuberculosis
La pirazinamida es un profármaco utilizado en infecciones contra Mycobacterium tuberculosis y su resistencia se debe principalmente a mutaciones en el gen pncA.En este estudio se realizó la detección de mutaciones puntuales de este gen, en aislamientos clínicos del estado de Nuevo León. Se elaborar...
Main Authors: | K. Y. Barrientos-Adrian, J. Flores Gracia, C.Molina-Torres, C. Venegas-Barrera, G. Guevara-Guerrero, A. Rendón-Pérez |
---|---|
Format: | Article |
Language: | Spanish |
Published: |
Universidad de Guanajuato
2020-05-01
|
Series: | Acta Universitaria |
Online Access: | https://www.actauniversitaria.ugto.mx/index.php/acta/article/view/2816/3512 |
Similar Items
-
Characterization of the mutation region of the Mycobacterium tuberculosis PncA protein
by: Wen-Chung Chen, et al.
Published: (2009) -
<it>pncA</it> mutations in clinical <it>Mycobacterium tuberculosis</it> isolates from Korea
by: Kim Cheol Min, et al.
Published: (2001-06-01) -
Pyrazinamide resistance and the pncA gene variability in mycobacterium tuberculosis and related bacteria
by: Bamaga, Mohammad Salih
Published: (2005) -
Novel Mutations in pncA Gene of Pyrazinamide Resistant Clinical Isolates of Mycobacterium tuberculosis
by: Manijeh Kahbazi, et al.
Published: (2018-04-01) -
Characteristics of <it>pncA </it>mutations in multidrug-resistant tuberculosis in Taiwan
by: Lee Yu-Chin, et al.
Published: (2011-09-01)